Literature DB >> 21191704

Gastric carcinoma with protein-losing gastroenteropathy: report of a case.

Manabu Yamamoto1, Ikuno Nishibuchi, Ayumi Matsuyama, Jin Okazaki, Tohru Utsunomiya, Shinichi Tsutsui, Megumu Fujiwara, Teruyoshi Ishida.   

Abstract

This report describes the successful treatment of a case of true gastric cancer presenting as protein-losing gastroenteropathy. A 58-year-old Japanese male presented gastric carcinoma. His serum albumin and total protein levels were 1.8 and 4.2 g/dl, respectively. He was diagnosed with gastric cancer with protein-losing gastroenteropathy based on (99m)Tc-human serum albumin scintigraphy. The patient underwent a total gastrectomy following neoadjuvant chemotherapy. There are 23 detailed case reports of gastric carcinoma with protein-losing gastroenteropathy. Most of these cases had large villous or cauliflower-like gastric tumors that were defined as papillary or well differentiated adenocarcinoma. Gastric cancer with protein-losing gastroenteropathy is extremely rare, but it can easily be diagnosed if the villous or cauliflower-like features are well defined.

Entities:  

Mesh:

Year:  2010        PMID: 21191704     DOI: 10.1007/s00595-009-4209-0

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  6 in total

1.  PROTEIN-LOSING GASTROENTEROPATHY IN PATIENTS WITH GASTROINTESTINAL CANCER.

Authors:  P T SUM; M M HOFFMAN; D R WEBSTER
Journal:  Can J Surg       Date:  1964-01       Impact factor: 2.089

2.  [Origin of proteins in the gastric juice; investigation with labeled blood protein].

Authors:  K H KIMBEL; K HEINKEL; W BORNER
Journal:  Arztl Wochensch       Date:  1956-07-13

3.  Tc-99m albumin scintigraphy in protein-losing gastroenteropathy caused by gastric polyposis.

Authors:  Y Inoue; T Ohtake; H Koga; J Nishikawa; K Yoshikawa; Y Sasaki
Journal:  Clin Nucl Med       Date:  1998-05       Impact factor: 7.794

4.  Protein-losing enteropathy from cap polyposis.

Authors:  N Oshitani; Y Moriyama; T Matsumoto; K Kobayashi; A Kitano
Journal:  Lancet       Date:  1995-12-09       Impact factor: 79.321

5.  Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer.

Authors:  Kazuhiro Yoshida; Motoki Ninomiya; Norihisa Takakura; Naoki Hirabayashi; Wataru Takiyama; Yuji Sato; Satoru Todo; Masanori Terashima; Mitsukazu Gotoh; Jyunnichi Sakamoto; Masahiko Nishiyama
Journal:  Clin Cancer Res       Date:  2006-06-01       Impact factor: 12.531

6.  Protein-losing enteropathy and hypoalbuminemia in AIDS.

Authors:  L Laine; F Garcia; K McGilligan; A Malinko; F R Sinatra; D W Thomas
Journal:  AIDS       Date:  1993-06       Impact factor: 4.177

  6 in total
  1 in total

1.  A Patient with a Large Gastric Tumor and Protein-Losing Gastroenteropathy Successfully Treated with Neoadjuvant TS-1 Combined with CDDP Therapy.

Authors:  Tatsuya Hashimoto; Yuichi Yamashita; Ryosuke Shibata; Keisuke Satou; Ippei Yamana; Kenji Maki; Shinsuke Takeno; Satoshi Nimura
Journal:  Case Rep Oncol       Date:  2014-11-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.